Gram-negative shock: approaches to treatment.
作者信息
Jacobson M A, Young L S
出版信息
J R Coll Physicians Lond. 1985 Oct;19(4):214-7.
Abstract
摘要
相似文献
1
Gram-negative shock: approaches to treatment.革兰氏阴性菌感染性休克：治疗方法
J R Coll Physicians Lond. 1985 Oct;19(4):214-7.
2
[Endotoxic (gram-negative) shock].[内毒素（革兰氏阴性）休克]
Lijec Vjesn. 1973 May;95(5):251-64.
3
[Use of opiate antagonists in the treatment of shock. Description of a case of shock treated with naloxone].[阿片类拮抗剂在休克治疗中的应用。一例用纳洛酮治疗休克的病例描述]
Pol Tyg Lek. 1983;38(51-52):1631-2.
4
Management of septic shock: new approaches.感染性休克的管理：新方法
Curr Clin Top Infect Dis. 1992;12:165-87.
5
[What is safe in the drug therapy of infection?].[感染药物治疗中的安全因素有哪些？]
Beitr Infusionther Klin Ernahr. 1983;10:196-203.
6
Antibiotic Combination Therapy for Patients With Gram-Negative Septic Shock.革兰氏阴性菌败血症休克患者的抗生素联合治疗
Crit Care Med. 2017 Nov;45(11):1933-1936. doi: 10.1097/CCM.0000000000002677.
7
Corticosteroids for the treatment of septic shock.用于治疗感染性休克的皮质类固醇。
Infect Dis Clin North Am. 1991 Dec;5(4):875-82.
8
Endotoxic shock.
Obstet Gynecol Annu. 1972;1:273-96.
9
[Neonatal bacterial infections].[新生儿细菌感染]
Pediatr Med Chir. 1986 Jul-Aug;8(4):471-4.
10
Monotherapy Is Adequate for Septic Shock Due to Gram-Negative Organisms.对于革兰氏阴性菌引起的感染性休克，单一疗法就足够了。
Crit Care Med. 2017 Nov;45(11):1930-1932. doi: 10.1097/CCM.0000000000002678.
本文引用的文献
1
Improved prognosis for granulocytopenic patients with gram-negative bacteremia.粒细胞减少症合并革兰氏阴性菌血症患者的预后改善。
Am J Med. 1980 May;68(5):643-8. doi: 10.1016/0002-9343(80)90243-0.
2
Septic shock and corticosteroids.脓毒性休克与皮质类固醇
N Engl J Med. 1981 Aug 20;305(8):456-8. doi: 10.1056/NEJM198108203050810.
3
The treatment of gram-negative bacteremia and shock.革兰氏阴性菌血症和休克的治疗。
N Engl J Med. 1982 Nov 11;307(20):1267-8. doi: 10.1056/NEJM198211113072010.
4
Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.大肠杆菌核心脂多糖诱导针对致死性b型流感嗜血杆菌感染的免疫
J Clin Invest. 1982 Apr;69(4):742-9. doi: 10.1172/jci110512.
5
Immunization against nosocomial infection.医院感染的免疫接种。
Am J Med. 1981 Feb;70(2):463-6. doi: 10.1016/0002-9343(81)90789-0.
6
Complement-induced granulocyte aggregation: an unsuspected mechanism of disease.补体诱导的粒细胞聚集：一种未被察觉的疾病机制。
N Engl J Med. 1980 Apr 3;302(14):789-94. doi: 10.1056/NEJM198004033021407.
7
Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.用人抗突变型大肠杆菌抗血清治疗革兰氏阴性菌血症和休克。
N Engl J Med. 1982 Nov 11;307(20):1225-30. doi: 10.1056/NEJM198211113072001.
8
Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients.在发热性粒细胞缺乏症患者中，头孢氧哌唑钠加哌拉西林与头孢氧哌唑钠加丁胺卡那霉素的对比研究
Am J Med. 1984 Sep;77(3):442-50. doi: 10.1016/0002-9343(84)90100-1.
9
Symposium on infectious complications of neoplastic disease (Part II). Immunoprophylaxis and serotherapy of bacterial infections.肿瘤疾病的感染并发症研讨会（第二部分）。细菌感染的免疫预防和血清疗法。
Am J Med. 1984 Apr;76(4):664-71. doi: 10.1016/0002-9343(84)90292-4.
10
The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study.大剂量皮质类固醇对感染性休克患者的影响。一项前瞻性对照研究。
N Engl J Med. 1984 Nov 1;311(18):1137-43. doi: 10.1056/NEJM198411013111801.
Zotero 插件